Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples